Skip to main content
Methodology published · Market data, model notes, and corrections process are public · Data policy · Corrections policy

NYSE · Healthcare · Financials

Thermo Fisher Scientific financials & valuation

Reported statements, fiscal periods and valuation definitions in one place.

Section freshness

Research as of Jun 27, 2026 · Prices as of Sep 29, 9:33 AM EDT · Fundamentals checked Sep 29, 9:27 AM EDT · Statements Jun 27, 2026

Financial statements

Show / hide line items

Revenue

44.56B

FY2025 · ended Dec 31, 2025

Operating Income

7.75B

FY2025 · ended Dec 31, 2025

Net Income

6.7B

FY2025 · ended Dec 31, 2025

Amounts in USD. B = billions · M = millions. Scroll horizontally for earlier periods.

Sources, units & calculation notes

TECHi unified data / SEC Companyfacts. Per-share figures are in USD/share; margins in %, debt/equity in ×. TTM sums four consecutive quarters; balance sheets remain period-end balances. Growth requires comparable positive values. EPS uses the provider’s reported share basis; missing direct quarters are unavailable, and mixed filing split bases are not summed. EPS growth and trend lines require matching documented accounting and split bases. Tab through controls; use arrow keys inside the table.

TMO annual income
Line item FY2025Ended Dec 31, 2025Filed Feb 26, 2026Source filing FY2024Ended Dec 31, 2024Filed Feb 26, 2026Source filing FY2023Ended Dec 31, 2023Filed Feb 26, 2026Source filing FY2022Ended Dec 31, 2022Filed Feb 20, 2025Source filing1Y change3Y annual growthTrend
44.56B42.88B42.86B44.92B3.9%-0.3%
6.7B6.34B6B—5.8%—
7.75B7.34B6.86B8.39B5.6%-2.6%

Earnings quality · Dec 31, 2025

Net income
6.7B
Free cash flow
6.29B
Stock-based compensation
310M
FCF / net income
93.9%
Accrual gap / revenue
-2.5%
Cash conversion
Moderate cash conversion

Accrual gap = (net income − operating cash flow) / revenue. TECHi descriptive thresholds: strong ≥100%, moderate 75–100%, weak <75%. CapEx timing, working capital and industry structure affect the ratio; it is not an accounting audit.

Download quarterly financial dataset

Changes between reports

Q2 Jun 27, 2026 versus Q1 Mar 28, 2026

Latest quarter compared with the preceding report. Margin changes are in percentage points (pp).

Revenue
11.99B↑ +9.0%
Previous: 11.01B · USD
Operating margin
17.40%↑ +0.5 pp
Previous: 16.93%
Net margin
14.47%↓ -0.5 pp
Previous: 15.00%
Cash
4.06B↑ +24.9%
Previous: 3.25B · USD
Debt
45.65B↓ -0.8%
Previous: 46.04B · USD
Inventory
5.63B↑ +2.4%
Previous: 5.5B · USD
Capex
450M↑ +19.7%
Previous: 376M · USD
Stock-based compensation
82M↓ -1.2%
Previous: 83M · USD

Reported-period comparison. Guidance and risk-factor changes require reading the filings.

Read the filings

Valuation & ratios

Multiples with negative or missing earnings are not meaningful. Annual free cash flow yield uses the latest fiscal year; provider forward multiples may use a different earnings horizon.

Loading dated valuation research…

All data sources

Search the dated figures used for this view. Each entry identifies its units, reporting period and calculation status.

How to use this page

Use this to decide whether the business supports the valuation.

Best for Revenue quality, margins, cash conversion, debt, and filing cadence.

Weak when One-time items or old filings dominate the most recent reported figures.

Browse all companies and funds
Research tools
US market hours

Regular hours: 9:30 AM–4:00 PM America/New_York

Next open: Checking…

Exchange calendar includes scheduled holidays and early closes. Extended-session prices appear separately only when supplied by the quote source.